CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 354 enrolled
Drug / intervention
Duloxetine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02248480
NCT02248480Phase 3Completed
CompareCT.gov

Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Osteoarthritis and Knee Pain in Japan

Eli Lilly and Company·interventional·Posted Sep 25, 2014·Updated Sep 26, 2019

In Brief

A Phase 3 clinical trial evaluating Duloxetine and Placebo for Osteoarthritis of the Knee. Completed, enrolled 354 participants across 1 site.

Detailed Summary

The main purpose of this study is to evaluate the efficacy of the study drug known as duloxetine in participants with chronic osteoarthritis (OA) and knee pain in Japan.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis of the Knee
CountriesJapan
CollaboratorsShionogi

Timeline

Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 25, 2014
Enrollment StartOct 1, 2014
Primary CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 11.8 years ago

Interventions

Duloxetinedrug

Administered orally

Placebodrug

Administered orally